Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Andreas von Ameln-Mayerhofer"'
Autor:
Richard Schäfer, Matthias Schwab, Georg Siegel, Andreas von Ameln-Mayerhofer, Marine Buadze, Ali Lourhmati, Hans-Peter Wendel, Torsten Kluba, Marcel A. Krueger, Carsten Calaminus, Eva Scheer, Massimo Dominici, Giulia Grisendi, Thorsten R. Doeppner, Jana Schlechter, Anne Kathrin Finzel, Dominic Gross, Roland Klaffschenkel, Frank K. Gehring, Gabriele Spohn, Anja Kretschmer, Karen Bieback, Eva-Maria Krämer-Albers, Kerstin Barth, Anne Eckert, Stefanie Elser, Joerg Schmehl, Claus D. Claussen, Erhard Seifried, Dirk M. Hermann, Hinnak Northoff, Lusine Danielyan
Publikováno v:
EBioMedicine, Vol 60, Iss , Pp 102987- (2020)
Background: Limited knowledge of stem cell therapies` mechanisms of action hampers their sustainable implementation into the clinic. Specifically, the interactions of transplanted stem cells with the host vasculature and its implications for their th
Externí odkaz:
https://doaj.org/article/cfdc3c5617b54f99af3c86514beec666
Autor:
Joachim Andreas Koeck, Heike Hilgarth, Andreas von Ameln-Mayerhofer, Damaris Meyn, Ruediger Warlich, Andreas Münstedt, Dagmar Horn, Christina König
Publikováno v:
Antibiotics, Vol 10, Iss 11, p 1330 (2021)
Patients in intensive care units (ICUs) are at high risk of drug–drug interactions (DDIs) due to polypharmacy. Little is known about type and frequency of DDIs within German ICUs. Clinical pharmacists’ interventions (PI) recorded in a national da
Externí odkaz:
https://doaj.org/article/a954d48872ce4c0a83e722015168be25
Autor:
Ruediger Warlich, Heike Hilgarth, Andreas von Ameln-Mayerhofer, Joachim Andreas Koeck, Dagmar Horn, Christina König, Damaris Meyn, Andreas Münstedt
Publikováno v:
Antibiotics
Volume 10
Issue 11
Antibiotics, Vol 10, Iss 1330, p 1330 (2021)
Volume 10
Issue 11
Antibiotics, Vol 10, Iss 1330, p 1330 (2021)
Patients in intensive care units (ICUs) are at high risk of drug–drug interactions (DDIs) due to polypharmacy. Little is known about type and frequency of DDIs within German ICUs. Clinical pharmacists’ interventions (PI) recorded in a national da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd4d8374c46ba008f1d8cd743284cdc
Autor:
Frank K. Gehring, Karen Bieback, Massimo Dominici, Marcel A. Krueger, Carsten Calaminus, Andreas von Ameln-Mayerhofer, Claus D. Claussen, Torsten Kluba, Stefanie Elser, Erhard Seifried, Anne Eckert, Giulia Grisendi, Georg Siegel, Jana Schlechter, Dirk M. Hermann, Richard Schäfer, Anne Kathrin Finzel, Dominic Gross, Hinnak Northoff, Roland A. Klaffschenkel, Kerstin Barth, Matthias Schwab, Eva-Maria Krämer-Albers, Thorsten R. Doeppner, Eva Scheer, Hans Peter Wendel, Lusine Danielyan, Anja Kretschmer, Marine Buadze, Ali Lourhmati, Gabriele Spohn, Joerg Schmehl
Publikováno v:
EBioMedicine, Vol 60, Iss, Pp 102987-(2020)
EBioMedicine
EBioMedicine
Background Limited knowledge of stem cell therapies` mechanisms of action hampers their sustainable implementation into the clinic. Specifically, the interactions of transplanted stem cells with the host vasculature and its implications for their the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1953aeb3e99e371dc6aa34de65c821b2
http://www.sciencedirect.com/science/article/pii/S2352396420303637
http://www.sciencedirect.com/science/article/pii/S2352396420303637
Publikováno v:
Behavioural Brain Research. 244:116-119
Behavioral sensitization to the repeated administration of a psychostimulant presumably plays a key role in the pathogenesis of addiction and schizophrenia. Among other psychostimulants, 3,4-methylenedioxymethamphetamine (MDMA) is known to produce be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af8403e80307f41bb91bcb17c9d0e82
https://doi.org/10.1016/j.bbr.2013.01.033
https://doi.org/10.1016/j.bbr.2013.01.033
Publikováno v:
Medizinische Monatsschrift fur Pharmazeuten. 38(10)
New oral anticoagulant drugs (NOAC) represent a promising alternative to the classical anticoagulant therapy with vitamin K antagonists like phenprocoumon or warfarin. Meanwhile, these substances are well implemented in the management of several indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6b2d0b8f614434f18b6cdfbdfeb28a8
https://pubmed.ncbi.nlm.nih.gov/26731856
https://pubmed.ncbi.nlm.nih.gov/26731856
Autor:
Vesna Sossi, Nadine Y. Lettfuss, Kristina Fischer, Andreas von Ameln-Mayerhofer, Bernd J. Pichler
Publikováno v:
NeuroImage. 63:423-433
In the context of Parkinson's disease, motor symptoms result from the degeneration of nigrostriatal neurons. Dopamine (DA) replacement using l-3,4-dihydroxyphenylalanine (L-DOPA) has been the treatment of choice in the early stages of the disease. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030dc472e9165f3a57f8c3c723fdbf25
https://doi.org/10.1016/j.neuroimage.2012.06.051
https://doi.org/10.1016/j.neuroimage.2012.06.051
Autor:
Adriane Gröger, Eva Küppers, Britta Wachter, Bernd J. Pichler, Andreas von Ameln-Mayerhofer, Rüdiger Sadler, Sonja Schürger, Hans-Joachim Wagner, Anna Speidel, Andreas Schmid, Jens Rolinger, Daniela Berg
Publikováno v:
Behavioural brain research 232(1), 148-158 (2012). doi:10.1016/j.bbr.2012.04.005
The neurotoxin 6-hydroxydopamine (6-OHDA) is frequently used in animal models to mimic Parkinson's disease. Imaging studies describe hyperintense signalling in regions close to the site of the 6-OHDA injection in T2-weighted (T2w) magnetic resonance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::827fea2ed870e27394eb4ad1b9329853
https://doi.org/10.1016/j.bbr.2012.04.005
https://doi.org/10.1016/j.bbr.2012.04.005
Autor:
Daniela Berg, Andreas von Ameln-Mayerhofer, Eva Kueppers, Britta Wachter, Hans-Jochen Wagner, Sonja Schürger, Jens Rolinger
Publikováno v:
Cell and Tissue Research. 342:147-160
Reactive astrogliosis is the universal response to any brain insult. It is characterized by cellular hypertrophy, up-regulation of the astrocyte marker glial fibrillary acidic protein (GFAP), and proliferation. The source of these proliferating cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f19af3f6a8c79d2bdae576632d3a37c
https://doi.org/10.1007/s00441-010-1061-x
https://doi.org/10.1007/s00441-010-1061-x
Publikováno v:
Addiction Biology. 15:35-44
Despite the great popularity of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) as a drug of abuse, not much is known about the detailed mechanisms of the acute and subchronic effects of the drug. There is especially a lack of information about the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6be5b13173ae65b235a9ea856df88e8
https://doi.org/10.1111/j.1369-1600.2009.00187.x
https://doi.org/10.1111/j.1369-1600.2009.00187.x